Caron, Barthelemy
Patin, Etienne
Rotival, Maxime
Charbit, Bruno
Albert, Matthew L.
Quintana-Murci, Lluis
Duffy, Darragh
Rausell, Antonio https://orcid.org/0000-0002-4832-6101
,
Abel, Laurent
Alcover, Andres
Aschard, Hugues
Bousso, Philippe
Bourke, Nollaig
Brodin, Petter
Bruhns, Pierre
Cerf-Bensussan, Nadine
Cumano, Ana
Demangel, Caroline
d’Enfert, Christophe
Deriano, Ludovic
Dillies, Marie-Agnès
Di Santo, James
Dromer, Françoise
Eberl, Gérard
Enninga, Jost
Fellay, Jacques
Gomperts-Boneca, Ivo
Hasan, Milena
Fontes, Magnus
Hedestam, Gunilla Karlsson
Hercberg, Serge
Ingersoll, Molly A.
Kenny, Rose Anne
Lantz, Olivier
Michel, Frédérique
Mouquet, Hugo
O’Farrelly, Cliona
Patin, Etienne
Pellegrini, Sandra
Pol, Stanislas
Rausell, Antonio
Rieux-Laucat, Frédéric
Rogge, Lars
Sakuntabhai, Anavaj
Schwartz, Olivier
Schwikowski, Benno
Shorte, Spencer
Tangy, Frédéric
Toubert, Antoine
Touvier, Mathilde
Ungeheuer, Marie-Noëlle
Zimmer, Christophe
Albert, Matthew L.
Duffy, Darragh
Quintana-Murci, Lluis
Funding for this research was provided by:
agence nationale de la recherche (ANR-10-LABX-69-01., Grant ANR-10-IAHU-01)
Article History
Received: 10 June 2021
Accepted: 15 February 2022
First Online: 9 March 2022
Declarations
:
: The clinical study was approved by the Comité de Protection des Personnes - Ouest 6 on June 13, 2012 and by the French Agence Nationale de Sécurité du Médicament on June 22, 2012, and has been performed in accordance with the Declaration of Helsinki. The protocol is registered under ClinicalTrials.gov (study# NCT01699893). Informed consent was obtained from participants after the nature and possible consequences of the studies were explained.
: Not applicable.
: M.L.A. is an employee of HIBIO, South San Francisco, California CA, 94080. The remaining authors declare that they have no competing interests.